1
|
Hawari M, Selim J, Djerada Z, Muraine M, Retout A, Thorel D. [Five-year extrusion risk of "2 petal" and "4 petal" evisceration techniques]. J Fr Ophtalmol 2024:104224. [PMID: 38862314 DOI: 10.1016/j.jfo.2024.104224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2023] [Revised: 12/13/2023] [Accepted: 12/15/2023] [Indexed: 06/13/2024]
Affiliation(s)
- M Hawari
- Service d'ophtalmologie, CHU de Rouen, 37, boulevard Gambetta, 76000 Rouen, France; Service de pharmacologie, EA3801, SFR CAP-Santé, CHU de Reims, 51, rue Cognacq-Jay, 51095 Reims cedex, France
| | - J Selim
- Département de réanimation-anesthésie, médecine péri-opératoire, CHU de Rouen, 37, boulevard Gambetta, 76000 Rouen, France; Université Rouen-Normandie, Inserm EnVI UMR 1096, 76000 Rouen, France; Service de pharmacologie, EA3801, SFR CAP-Santé, CHU de Reims, 51, rue Cognacq-Jay, 51095 Reims cedex, France
| | - Z Djerada
- Université Rouen-Normandie, Inserm EnVI UMR 1096, 76000 Rouen, France; Service de pharmacologie, EA3801, SFR CAP-Santé, CHU de Reims, 51, rue Cognacq-Jay, 51095 Reims cedex, France
| | - M Muraine
- Service d'ophtalmologie, CHU de Rouen, 37, boulevard Gambetta, 76000 Rouen, France; Service de pharmacologie, EA3801, SFR CAP-Santé, CHU de Reims, 51, rue Cognacq-Jay, 51095 Reims cedex, France
| | - A Retout
- Service d'ophtalmologie, CHU de Rouen, 37, boulevard Gambetta, 76000 Rouen, France; Service de pharmacologie, EA3801, SFR CAP-Santé, CHU de Reims, 51, rue Cognacq-Jay, 51095 Reims cedex, France
| | - D Thorel
- Service d'ophtalmologie, CHU de Rouen, 37, boulevard Gambetta, 76000 Rouen, France; Service de pharmacologie, EA3801, SFR CAP-Santé, CHU de Reims, 51, rue Cognacq-Jay, 51095 Reims cedex, France.
| |
Collapse
|
2
|
Svedberg K. Outcome of eviscerations and enucleations at a Swedish tertiary referral centre between 2008 and 2019: improved surgical management leading to reduced complication rate. Orbit 2023; 42:174-180. [PMID: 35611572 DOI: 10.1080/01676830.2022.2078844] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
PURPOSE The aim of this study was to investigate the results of all eviscerations and enucleations performed at the Department of Ophthalmology, Sahlgrenska University Hospital, during 2008-2019 and to compare them with previously collected data from 1999 to 2007. METHODS This was a retrospective investigation using the medical records for all patients having had an evisceration or an enucleation at the Department of Ophthalmology, Sahlgrenska University Hospital, during the two defined periods of time. Main outcome measure was postoperative complications. RESULTS During 1999-2007, 181 surgeries were performed, 100 with implants, and 28/100 exposed implants and 9/100 removed implants were recorded during follow-up. During 2008-2019, 250 operations were performed with 158 implants, and there were 3/158 exposed implants and 2/158 extruded implants. Two ruptures of the surgical wound without implant exposure were noted, and one implant was exchanged. The reduction of exposed implants between the two periods was statistically significant (p < .001, Chi-square test). In enucleations, the use of one kind of porous polyethylene implant in the recent study period replaced a multitude of implants in the earlier study period. In eviscerations, the major change between the two study periods was the introduction of the split sclera technique and smaller implant size. CONCLUSION The change in surgical technique between the two periods led to a significant reduction in implant-related complications.
Collapse
Affiliation(s)
- Karin Svedberg
- Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.,Department of Ophthalmology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden
| |
Collapse
|
3
|
Calluaud G, Amelot A, Kulker D, Laure B, Pare A. Management of post enucleation socket syndrome patients - A retrospective study. J Craniomaxillofac Surg 2021; 50:163-169. [PMID: 35042651 DOI: 10.1016/j.jcms.2021.12.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2021] [Revised: 10/02/2021] [Accepted: 12/10/2021] [Indexed: 10/19/2022] Open
Abstract
The aim of this retrospective monocentric study was to report the outcomes following the correction of post enucleation socket syndrome (PESS) as well as the factors predicting for a multistep management. Patients were included, if they had received surgery to manage PESS. Demographics and patient history were collected. The symptoms of PESS were clinically rated by the same surgeon and ocularist, preoperatively and after each procedure. The surgery was considered as successful when no PESS clinical symptoms were observed. A prognostic study was performed to investigate the surgical outcomes. RESULTS: Thirty-six patients were included and eight of them had their PESS corrected after the first surgery. In the multivariate analysis (MVA), the deep upper lid sulcus symptom remained the main significant factor associated with an incomplete correction after the first surgery (OR 45.5, IC 95% (3.481-594.6), p = 0.004). For further corrections, the ptosis was the only significant prognostic factor requiring several surgeries (p = 0.005). At the end of the management, 94.4% of the patients had satisfying outcomes. CONCLUSIONS: The management of a PESS involves the correction of both the orbital cavity and the soft tissues. Although its correction is complex and time consuming in the majority of cases, the patients should be informed that the final cosmetic outcomes remain good at the expense of several surgeries.
Collapse
Affiliation(s)
- Gauthier Calluaud
- Department of Maxillofacial and Facial Plastic Surgery, Trousseau Hospital, University Hospital Center of Tours, Tours, France; University of François Rabelais, School of Medicine, Tours, France
| | - Aymeric Amelot
- University of François Rabelais, School of Medicine, Tours, France; Department of Neurosurgery, Bretonneau Hospital, University Hospital Center of Tours, Tours, France
| | - Dimitri Kulker
- Department of Maxillofacial and Facial Plastic Surgery, Trousseau Hospital, University Hospital Center of Tours, Tours, France; University of François Rabelais, School of Medicine, Tours, France
| | - Boris Laure
- Department of Maxillofacial and Facial Plastic Surgery, Trousseau Hospital, University Hospital Center of Tours, Tours, France; University of François Rabelais, School of Medicine, Tours, France; Reference Center for Rare Craniostenose and Craniofacial Malformations CRANIOST, France.
| | - Arnaud Pare
- Department of Maxillofacial and Facial Plastic Surgery, Trousseau Hospital, University Hospital Center of Tours, Tours, France; University of François Rabelais, School of Medicine, Tours, France
| |
Collapse
|